The Beijing hub is crucial to our vision of expanding in Asia. Our Healthcare business uniquely combines the assets of a leading science and technology pioneer with a deep-rooted tradition in pharmaceutical science – both are highly regarded in China. Research activities at the Beijing hub focus mainly on biomarker research, including pharmacogenomics and bioanalytics.
The professional development of the more than 150 employees based here is a key priority for us. We foster their talent and curiosity with world-class training on cutting-edge research topics and technologies, and provide them with opportunities to interact with renowned scientists and clinical experts based in China. By leading drug development for local clinical trials and by participating in global clinical trials from Beijing, we can leverage our expertise to liaise more effectively with government stakeholders, academic institutions and other research-oriented organizations.